IP Library › Granted Patent US 12,644,827
Granted Patent B2
US 12,644,827 · App. 18/919,157 · Granted Jun 2, 2026

Systems and methods for panel design in flow cytometry

Inventor: Michael Kapinsky (Pollenreid, DE)
Assignee: BECKMAN COULTER, INC.
G01N21/255G01N15/14G01N15/1425G01N15/1434G01N15/01G01N2015/1006G01N2015/1402G01N2015/1477G01N2201/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,644,827
App. No.
18/919,157
Granted
Jun 2, 2026
Kind
B2
Abstract

Embodiments of the present invention encompass systems and methods for determining detection limits for various antibody-dye conjugates for flow cytometry. Exemplary techniques involve a linear superpositioning approach of spillover-induced enlargements of normally distributed measurement errors.

Claims (40)

1 . A method of designing a probe panel for a flow cytometer, the method comprising:

identifying a first probe, a second probe, and a third probe;

identifying a plurality of possible probe panels, each possible probe panel including a combination of the first probe, the second probe, or the third probe, each probe having a possible label associated thereto:

evaluating a first possible probe panel by determining a detection limit of the first probe based on spectrum spillover effects of combination of the second probe and its associated possible label;

evaluating a second possible probe panel by determining a detection limit of the second probe based on spectrum spillover effects of the combination of the third probe and its associated possible label; and

selecting the probe panel from the plurality of possible probe panels based on the detection limits determined.

2 . The method of claim 1 , where at least one of the first probe, the second probe, and the third probe specifically binds to an antigen.

3 . The method of claim 1 , wherein at least one of the first probe, the second probe, and the third probe specifically binds to an analyte.

4 . The method of claim 1 , wherein evaluating the first possible probe panel includes determining the detection limit of the first probe based in part on a coexpression pattern of antigens associated with the first probe and the second probe.

5 . The method of claim 4 , wherein the coexpression pattern of antigens further comprises coexpression relationships between antigens for a particular cell type.

6 . The method of claim 4 , wherein spectrum spillover effects of combination of the second probe and its associated label is determined to be zero if the coexpression pattern of antigens associated with the first probe and the second probe is mutually exclusive.

7 . The method of claim 4 , wherein spectrum spillover effects of combination of the second probe and its associated label is determined to be zero if the antigen associated with the second probe is a descendent of the antigen associated with the first probe.

8 . The method of claim 1 , wherein spectrum spillover effects of combination of the second probe and its associated label are quantified as a function of a distortion factor and an antigenic coexpression pattern.

9 . The method of claim 1 , wherein spectrum spillover effects of combination of the second probe and its associated label are quantified as a function of an expected antigen density on a target cell.

10 . The method of claim 1 further comprising displaying a graphical representation of a population distribution of expected signals for a pair of probes in the selected probe panel.

11 . The method of claim 10 , wherein displaying the graphical representation of the population distribution includes displaying the determined detection limit of the first probe and the second probe.

12 . The method of claim 10 , wherein the graphical representation of the population distribution includes displaying the background distortion.

13 . The method of claim 10 , wherein the graphical representation of the population distribution includes displaying an expression pattern of antigens associated with any one or more of the first probe, second probe or third probe, optionally including any coexpression of the antigens.

14 . A method of designing a probe panel for a flow cytometer, the method comprising:

identifying a first probe, a second probe, and a third probe;

identifying a plurality of possible probe panels, each possible probe panel including a combination of the first probe, the second probe, or the third probe, each probe having a possible label associated thereto:

evaluating a first possible probe panel by determining a detection limit of the first probe based on spectrum spillover effects of combination of the second probe and its associated possible label;

evaluating a second possible probe panel by determining a detection limit of the second probe based on spectrum spillover effects of the combination of the third probe and its associated possible label;

selecting the probe panel from the plurality of possible probe panels based on the detection limits determined; and

displaying a graphical representation of a population distribution of expected signals for a pair of probes in the selected probe panel,

wherein evaluating the first possible probe panel includes determining the detection limit of the first probe based in part on a coexpression pattern of antigens associated with the first probe and the second probe.

15 . The method of claim 14 , wherein displaying the graphical representation of the population distribution includes displaying the determined detection limit of the first probe and the second probe.

16 . The method of claim 14 , wherein the graphical representation of the population distribution includes displaying the background distortion.

17 . The method of claim 14 , wherein the graphical representation of the population distribution includes displaying an expression pattern of antigens associated with any one or more of the first probe, second probe or third probe, optionally including any coexpression of the antigens.

18 . A method of designing a probe panel for a flow cytometer, the method comprising:

identifying a first probe, a second probe, and a third probe;

identifying a plurality of possible probe panels, each possible probe panel including a combination of the first probe, the second probe, or the third probe, each probe having a possible label associated thereto:

evaluating a first possible probe panel by determining a detection limit of the first probe based on spectrum spillover effects of combination of the second probe and its associated possible label;

evaluating a second possible probe panel by determining a detection limit of the second probe based on spectrum spillover effects of the combination of the third probe and its associated possible label;

selecting the probe panel from the plurality of possible probe panels based on the detection limits determined; and

displaying a graphical representation of a population distribution of expected signals for a pair of probes in the selected probe panel,

wherein evaluating the first possible probe panel includes determining the detection limit of the first probe based in part on a coexpression pattern of antigens associated with the first probe and the second probe,

wherein the coexpression pattern of antigens further comprises coexpression relationships between antigens for a particular cell type.

19 . The method of claim 18 , wherein spectrum spillover effects of combination of the second probe and its associated label is determined to be zero if the coexpression pattern of antigens associated with the first probe and the second probe is mutually exclusive.

20 . The method of claim 18 , wherein spectrum spillover effects of combination of the second probe and its associated label is determined to be zero if the antigen associated with the second probe is a descendent of the antigen associated with the first probe.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2026
From: KAPINSKY, MICHAEL
To: BECKMAN COULTER, INC.
Reel/Frame 074502/0846 →
Continuity (5)
Division 18344805 · Jun 29, 2023
Division 16671795 · Nov 1, 2019
Division 14776891
Provisional Application 61791492 · Mar 15, 2013
Related Publication 20250035539A1 · Jan 30, 2025
References Cited (56)
US 4661913A · Wu et al. · 1987 [cited by applicant]
US 4987086A · Brosnan et al. · 1991 [cited by applicant]
US 5073497A · Schwartz · 1991 [cited by applicant]
US 5656499A · Chupp et al. · 1997 [cited by applicant]
US 6228652B1 · Rodriguez et al. · 2001 [cited by applicant]
US 9096885B2 · Vidal et al. · 2015 [cited by applicant]
US 10502678B2 · Kapinsky · 2019 [cited by applicant]
US 11733155B2 · Kapinsky · 2023 [cited by applicant]
US 12146827B2 · Kapinsky · 2024 [cited by applicant]
US 20010049689A1 · Mentzer · 2001 [cited by applicant]
US 20040119974A1 · Bishop et al. · 2004 [cited by applicant]
US 20040214171A1 · Yamashita et al. · 2004 [cited by applicant]
US 20050123549A1 · Payne et al. · 2005 [cited by applicant]
US 20050170373A1 · Monforte · 2005 [cited by applicant]
US 20060269970A1 · Paul et al. · 2006 [cited by applicant]
US 20080194508A1 · Christensen et al. · 2008 [cited by applicant]
US 20090216478A1 · Estevez-Labori · 2009 [cited by applicant]
US 20090221005A1 · Kelleher et al. · 2009 [cited by applicant]
US 20100012853A1 · Parks et al. · 2010 [cited by applicant]
US 20100028865A1 · Groth et al. · 2010 [cited by applicant]
US 20100120059A1 · Yan et al. · 2010 [cited by applicant]
US 20100302536A1 · Ball et al. · 2010 [cited by applicant]
US 20110204259A1 · Rogers et al. · 2011 [cited by applicant]
US 20110282870A1 · Herzenberg et al. · 2011 [cited by applicant]
US 20110312511A1 · Winquist et al. · 2011 [cited by applicant]
US 20120019825A1 · Thomas · 2012 [cited by applicant]
US 20120056103A1 · Sakai · 2012 [cited by applicant]
US 20120231473A1 · Han · 2012 [cited by applicant]
AU 2014228537A1 · 2015 [cited by applicant]
AU 2018206722A1 · 2018 [cited by applicant]
AU 2018206722B2 · 2020 [cited by applicant]
CA 2227895 · 1997 [cited by applicant]
CN 101669031 · 2010 [cited by applicant]
CN 105051521A · 2015 [cited by applicant]
CN 105051521B · 2020 [cited by applicant]
CN 111537426A · 2020 [cited by applicant]
EP 2972213 · 2016 [cited by applicant]
JP 2003083894 · 2003 [cited by applicant]
JP 2011085587 · 2011 [cited by applicant]
JP 2016517000A · 2016 [cited by applicant]
JP 6437522B2 · 2018 [cited by applicant]
WO 2012178166A1 · 2012 [cited by applicant]
WO 2013003498A2 · 2013 [cited by applicant]
WO 2014144826A1 · 2014 [cited by applicant]
“FlowJo Panel Wizard”, Tree Star, Inc., software product information, [online], retrieved from internet: URL: http://www.flowjo.com/, 4 pages (2010). [cited by applicant]
European Application Serial No. 20176567.4, Extended European Search Report mailed Sep. 4, 2020, 8 pgs. [cited by applicant]
Kapinsky, “Designing Panels for Multicolor Phenotyping”, 1st US SINO Flow Cytometry Workshop, Shanghai, China, Apr. 23, 2012, pp. 1-59. [cited by applicant]
Kapinsky, “Designing Panels for Multicolor Phenotyping”, Beckman Coulter Flow Cytometry, Clinical Flow Symposium, Hong Kong Institute of Medicine Laboratory Sciences, Ltd., Apr. 6-7, 2013, 57 pages. [cited by applicant]
Kapinsky, M., “Beyond Matching Dim Expression Densities with Bright Fluorochromes: A Novel Approach to Design Multicolor Applications”, Beckman Coulter Life Science, Inc., Krefeld, Germany, Poster, 2012, 1 page. [cited by applicant]
Maecker, H. et al., “Selecting Reagents for Multicolor Flow Cytometry”, BD Biosciences, Application Note, Jun. 2012, 8 pages. [cited by applicant]
International Application Serial No. PCT/US2014/029400, International Preliminary Report on Patentability dated May 14, 2015, 7 pages. [cited by applicant]
International Application Serial No. PCT/US2014/029400, International Search Report mailed Jul. 7, 2014 , 4 pages. [cited by applicant]
International Application Serial No. PCT/US2014/029400, Written Opinion mailed Jul. 7, 2014, 6 pages. [cited by applicant]
Extended European Search Report for Application No. 25174864.6 mailed Aug. 4, 2025. [cited by applicant]
Barsalou et al., “Management of Complex Immunogenetics Information Using an Enhanced Relational Model,” Computers and Biomedical Research, vol. 24, pp. 476-498 (1991). [cited by applicant]
Hulspas et al., “Considerations for the Control of Background Fluorescence in Clinical Flow Cytometry,” Cytometry Part B (Clinical Cytometry) 76B:355-364 (2009). [cited by applicant]